Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.
Clinical trial NCT04869579 · UNKNOWN
Trial details
- NCT number
- NCT04869579
- Sponsor
- CHRISTUS Health
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-15
- Primary completion
- 2021-11-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.